ArticleDiabetology & metabolic syndrome2014

Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes.

Kenjiro Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.